Benzinga's Small Cap Movers for Friday March 8, 2013
Below are highlights from Benzinga's daily coverage of small cap securities making big moves:
Shares of Green Innovations (OTC: GNIN), the Miami, FL exclusive licensed North American distributor of American Hygienics Corporation's 100% tree-free bamboo-based product line, including personal care and paper-based goods, rose 5% Friday on 6 times average volume.
Green Innovations announced Friday, that its wholly-owned subsidiary, Green Hygienics, has begun fulfilling several recently announced product purchase orders to some of its newest southern California retailers and distributors, including Big Saver Foods and Cardenas Markets. Green Hygienics products will now be available in over 1,300 locations in California.
Green Innovations closed at $1.82 on Friday.
Information Services Group
Information Services Group (NASDAQ: III), the Stamford, CT technology insights, market intelligence and advisory services company, rose 26% Friday on 4 times average volume.
Information Services Group announced Thursday, financial results for the fourth quarter and year ended December 31, 2012. ISG reported fourth quarter revenues of $49.5 million, up 11% versus the prior year in constant currency, as well as on a reported basis. Revenues were $27.0 million up 31% in the Americas offsetting a 6% decline in Europe to $16.7 million and a 2% decline in Asia Pacific to $5.8 million.
Diluted adjusted fourth quarter EPS in 2012 was $0.05 compared with $0.03 for the fourth quarter of 2011. Diluted adjusted EPS excluding acquisition-related and restructuring costs for the fourth quarter of 2011 was $0.05.
Information Services Group closed at $1.82 on Friday.
Shares of Oxygen Biotherapeutics (NASDAQ: OXBT), the Morrisville, NC medical and cosmetic products company, rose 19% Friday on 51 times average volume.
Oxygen Biotherapeutics was mentioned positively in an article in TheStreet.com's Stockpickr web site.
Oxygen Biotherapeutics closed at $0.30 on Friday.
The information in this article is taken from public sources, press releases, and websites that cannot always be verified. Please note that investing in microcap stocks is highly speculative. The companies mentioned here are for information purposes only. Benzinga makes no claim as to the suitability of these stocks as an investment. Neither Benzinga nor its staff recommend that you buy, sell, or hold any security. We do not offer investment advice, personalized or otherwise. Benzinga recommends that you conduct your own due diligence and consult a certified financial professional for personalized advice about your financial situation.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.